Harvard Bioscience's total assets for Q3 2024 were $131.24M, an increase of 1.81% from the previous quarter. HBIO total liabilities were $65.92M for the fiscal quarter, a 6.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.